Data from Incyte's Dermatology Portfolio Accepted for Presentation at the 2022 European Academy of Dermatology and Venereology (EADV) Congress Seite 1

24.08.2022 - Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV) Congress, held September 7-10, 2022, in Milan ... Seite 1

Related Keywords

,Free Communications In Miscellaneous ,Mental Health ,Ruxolitinib Cream ,Ev Phase ,Free Communications ,Patient Demographics ,Baseline Clinical Characteristics ,Subgroup Analysis ,Two Randomized Phase ,Pigmentary Disorders ,Psychosocial Burden Among Patients Living ,Vitiligo In Europe ,Treatment History ,Burden Among Patients ,Disease Severity ,Incyte ,